Indications and uses
Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
Lidexa™ (Lidocaine Hydrochloride) Cream 38.8
Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
For external use only. Not for ophthalmic use.
Avoid contact with eyes.
Excessive application may result in increased systemic absorption.
Keep out of reach of children.
Use only as directed. If irritation occurs, discontinue use and consult a healthcare provider.
Localized skin reactions such as redness, irritation, or rash may occur.
For topical use only.
Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
Lidexa™ (Lidocaine Hydrochloride 38.8 mg/g) is supplied as a white topical cream in a 3 oz (85 g) tube.
NDC 85477-330-07
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0854770330078 | GTIN-13: 0854770330078 EAN-13: 0854770330078 GTIN-12: 854770330078 UPC-A: 854770330078 GTIN storage (14 digits): 00854770330078 | lidexa-1.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85477-330-07 | Lidexa | 85 g in 1 BOTTLE, PUMP | CREAM | 85 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85477-330-07 | GM - Gram | 85477-330 | 012decf9-a544-484e-9f6a-772a00331985 | 1 | 2026-04-20 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85477-330 | 85477-330-07 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LIDOCAINE | 98PI200987 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidexa | LIDEXA | Oncora Pharma, LLC | 46d6b3b8-3a9a-44c2-b807-a32f24945f4a | 2026-02-27 | Warnings, Adverse reactions | 85477-330-07 85477-330 85477033007 cb6c85bc-f245-431d-8ded-4a4d8c83dbb2 46d6b3b8-3a9a-44c2-b807-a32f24945f4a |
Adverse event summaries are temporarily unavailable. Other product information remains available.